Oncology

October 18th, 2017 More than half (57%) of cancer drugs authorised by the European Medicines Agency (EMA) between 2009 and 2013 came onto the market without any clear evidence they improved the quality or quantity of patients’ lives, according to research from...

September 13th, 2017 Some stroke survivors may have 50% higher risk of underlying cancer, according to an observational study presented at the ESMO 2017 Congress in Madrid. “Post-mortem studies have suggested that cancer can develop after a stroke, but the...
Page 1 of 39123...

Thank you for subscribing to MedicalBrief


MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.


Thank you for taking the time to complete the form.